Limits...
Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion.

Thews O, Hummel M, Kelleher DK, Lecher B, Vaupel P - Br. J. Cancer (2002)

Bottom Line: Perfusion was performed by cannulation of the femoral artery and vein in rats bearing DS-sarcoma on the hind foot dorsum.Following equilibration, nifedipine was continuously infused for 30 min (8.3 microg min(-1) kg(-1) BW).Despite the increased oxygen availability (+63%) seen upon application of this calcium channel blocker, nifedipine does not result in a substantial reduction of tumour hypoxia, most probably due to an increase in O(2) uptake with rising O(2) supply to the tumour-bearing hind limb.

View Article: PubMed Central - PubMed

Affiliation: Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, 55099 Mainz, Germany. OLTHEWS@uni-mainz.de

Show MeSH

Related in: MedlinePlus

Perfusate flow rate during isolated limb perfusion upon application of nifedipine or vehicle alone (gray bar). Data represent mean±s.e.m. (n=number of perfusion experiments).
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2376281&req=5

fig2: Perfusate flow rate during isolated limb perfusion upon application of nifedipine or vehicle alone (gray bar). Data represent mean±s.e.m. (n=number of perfusion experiments).

Mentions: Baseline PP in the isolated-perfused leg before administration of nifedipine or vehicle was 141±8 and 131±7 mmHg, respectively, at comparable baseline perfusate flow rates of 1.09±0.10 ml min−1 in the nifedipine group and of 1.16±0.12 ml min−1 in control animals. Upon nifedipine application, PP initially dropped (with lowest values at t=3 min) to 81% of the baseline value. Thereafter however, the decrease was intentionally compensated by the increased perfusate flow rate resulting in a constant PP of between 130 and 135 mmHg. During nifedipine application, the perfusate flow rate had to be increased by almost 100% in order to maintain a constant PP (Figure 2Figure 2


Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion.

Thews O, Hummel M, Kelleher DK, Lecher B, Vaupel P - Br. J. Cancer (2002)

Perfusate flow rate during isolated limb perfusion upon application of nifedipine or vehicle alone (gray bar). Data represent mean±s.e.m. (n=number of perfusion experiments).
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2376281&req=5

fig2: Perfusate flow rate during isolated limb perfusion upon application of nifedipine or vehicle alone (gray bar). Data represent mean±s.e.m. (n=number of perfusion experiments).
Mentions: Baseline PP in the isolated-perfused leg before administration of nifedipine or vehicle was 141±8 and 131±7 mmHg, respectively, at comparable baseline perfusate flow rates of 1.09±0.10 ml min−1 in the nifedipine group and of 1.16±0.12 ml min−1 in control animals. Upon nifedipine application, PP initially dropped (with lowest values at t=3 min) to 81% of the baseline value. Thereafter however, the decrease was intentionally compensated by the increased perfusate flow rate resulting in a constant PP of between 130 and 135 mmHg. During nifedipine application, the perfusate flow rate had to be increased by almost 100% in order to maintain a constant PP (Figure 2Figure 2

Bottom Line: Perfusion was performed by cannulation of the femoral artery and vein in rats bearing DS-sarcoma on the hind foot dorsum.Following equilibration, nifedipine was continuously infused for 30 min (8.3 microg min(-1) kg(-1) BW).Despite the increased oxygen availability (+63%) seen upon application of this calcium channel blocker, nifedipine does not result in a substantial reduction of tumour hypoxia, most probably due to an increase in O(2) uptake with rising O(2) supply to the tumour-bearing hind limb.

View Article: PubMed Central - PubMed

Affiliation: Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, 55099 Mainz, Germany. OLTHEWS@uni-mainz.de

Show MeSH
Related in: MedlinePlus